US 11987821
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
granted A61KA61K35/12A61K38/45
Quick answer
US patent 11987821 (Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy) held by Entrada Therapeutics, Inc. expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Entrada Therapeutics, Inc.
- Grant date
- Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K35/12, A61K38/45, A61K47/60, A61K47/645